newsfilter
← Latest News
GlobeNewswire·

Orgenesis Reports Revenue Growth of 364% for 2021 and Provides Business Update

GERMANTOWN, Md., March 30, 2022 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ:ORGS) ("Orgenesis" or the "Company"), a global biotech company working to unlock the full potential of cell and gene therapies, today reports its financial results for the year